These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27057987)

  • 1. Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.
    Lunemann S; Martrus G; Hölzemer A; Chapel A; Ziegler M; Körner C; Garcia Beltran W; Carrington M; Wedemeyer H; Altfeld M
    J Hepatol; 2016 Aug; 65(2):252-8. PubMed ID: 27057987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.
    Hölzemer A; Thobakgale CF; Jimenez Cruz CA; Garcia-Beltran WF; Carlson JM; van Teijlingen NH; Mann JK; Jaggernath M; Kang SG; Körner C; Chung AW; Schafer JL; Evans DT; Alter G; Walker BD; Goulder PJ; Carrington M; Hartmann P; Pertel T; Zhou R; Ndung'u T; Altfeld M
    PLoS Med; 2015 Nov; 12(11):e1001900; discussion e1001900. PubMed ID: 26575988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
    Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
    Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 induced changes in HLA-C*03 :  04-presented peptide repertoires lead to reduced engagement of inhibitory natural killer cell receptors.
    Ziegler MC; Nelde A; Weber JK; Schreitmüller CM; Martrus G; Huynh T; Bunders MJ; Lunemann S; Stevanovic S; Zhou R; Altfeld M
    AIDS; 2020 Oct; 34(12):1713-1723. PubMed ID: 32501836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function.
    van Teijlingen NH; Hölzemer A; Körner C; García-Beltrán WF; Schafer JL; Fadda L; Suscovich TJ; Brander C; Carrington M; Evans DT; van Baarle D; Altfeld M
    AIDS; 2014 Jun; 28(10):1399-408. PubMed ID: 24785948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.
    Thoens C; Berger C; Trippler M; Siemann H; Lutterbeck M; Broering R; Schlaak J; Heinemann FM; Heinold A; Nattermann J; Scherbaum N; Alter G; Timm J
    J Hepatol; 2014 Sep; 61(3):475-81. PubMed ID: 24780303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.
    Sim MJ; Malaker SA; Khan A; Stowell JM; Shabanowitz J; Peterson ME; Rajagopalan S; Hunt DF; Altmann DM; Long EO; Boyton RJ
    Front Immunol; 2017; 8():193. PubMed ID: 28352266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.
    Fadda L; Körner C; Kumar S; van Teijlingen NH; Piechocka-Trocha A; Carrington M; Altfeld M
    PLoS Pathog; 2012; 8(7):e1002805. PubMed ID: 22807681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable Frequencies of HLA-C
    Ziegler MC; Grañana FB; Garcia-Beltran WF; Schulze Zur Wiesch J; Hoffmann C; Rechtien A; Lunemann S; Altfeld M
    Front Immunol; 2018; 9():2361. PubMed ID: 30386333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.
    Cassidy S; Mukherjee S; Myint TM; Mbiribindi B; North H; Traherne J; Mulder A; Claas FH; Purbhoo MA; Das J; Khakoo SI
    Eur J Immunol; 2015 Feb; 45(2):492-500. PubMed ID: 25359276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.
    Hirayasu K; Ohashi J; Kashiwase K; Hananantachai H; Naka I; Ogawa A; Takanashi M; Satake M; Nakajima K; Parham P; Arase H; Tokunaga K; Patarapotikul J; Yabe T
    PLoS Pathog; 2012; 8(3):e1002565. PubMed ID: 22412373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.
    Knapp S; Warshow U; Hegazy D; Brackenbury L; Guha IN; Fowell A; Little AM; Alexander GJ; Rosenberg WM; Cramp ME; Khakoo SI
    Hepatology; 2010 Apr; 51(4):1168-75. PubMed ID: 20077564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.
    Vidal-Castiñeira JR; López-Vázquez A; Díaz-Peña R; Alonso-Arias R; Martínez-Borra J; Pérez R; Fernández-Suárez J; Melón S; Prieto J; Rodrigo L; López-Larrea C
    J Virol; 2010 Jan; 84(1):475-81. PubMed ID: 19846535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
    Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
    J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
    Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
    J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2
    Wauquier N; Petitdemange C; Tarantino N; Maucourant C; Coomber M; Lungay V; Bangura J; Debré P; Vieillard V
    EBioMedicine; 2019 Feb; 40():605-613. PubMed ID: 30711514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity.
    Rajagopalan S; Long EO
    J Exp Med; 1997 Apr; 185(8):1523-8. PubMed ID: 9126935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
    Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
    Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
    Shan Z; Huang J; Liao Q; Huang K; Wang M; Xu R; Tang X; Zhang W; Nelson K; Fu Y; Li C; Rong X
    Transfusion; 2018 Apr; 58(4):1028-1035. PubMed ID: 29446443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.